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Abstract Bone marrow-derived mesenchymal stem cells (MSCs) are of therapeutic interest in a variety of neurological
diseases. In this study, we wished to determine whether human MSCs secrete factors which protect cultured rodent cortical
neurons from death by trophic factor withdrawal or nitric oxide (NO) exposure. Medium conditioned by MSCs attenuated
neuronal death under these conditions, a process which was dependent on intact PI3kinase/Akt pathway signaling. Trophic
withdrawal and NO exposure in cultured cortical neurons led to reduction in Akt signaling pathways, whereas NO
administration activated p38 MAPkinase in neuronal cultures. Addition of MSC-conditioned medium significantly activated
the PI3kinase/Akt pathway and in neurons exposed to NO, MSC-conditioned medium reduced p38 signaling. We show
that MSCs secrete brain-derived neurotrophic factor (BDNF) and addition of anti-BDNF neutralising antibodies to
MSC-conditioned medium attenuated its neuroprotective effect. Exposure of neurons to BDNF increased activation of
Akt pathways and protected neurons from trophic factor withdrawal. These observations determine the mechanisms of
neuroprotection offered by MSC-derived factors and suggest an important role for BDNF in neuronal protection.
© 2009 Elsevier B.V. All rights reserved.Abbreviations: BDNF, brain-derived neurotrophic factor; DIV,
days in vitro; DMEM, Dulbecco's modified Eagles medium; EAE,
experimental autoimmune encephalomyelitis; MAPkinase, mitogen-
activated protein kinase; MIN, DMEM supplemented with chemically
defined medium with no serum; MNC, mononuclear cells; MSC,
mesenchymal stem cell; NGF, nerve growth factor; NO, nitric oxide;
PI3kinase, phosphatidylinositol 3-kinase.
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In recent years, there has been considerable interest in the
potential of stem cells as therapeutic agents in neurological
diseases (Lindvall and Kokaia, 2006). Specifically, autologous
human bone marrow-derived mesenchymal stem cell (MSC)
transplantation offers significant potential, since it avoids
problems of rejection and many ethical issues associated
with other stem cell-based therapies (Rice and Scolding,
2008). In neurological diseases it has been postulated that
stem cell therapies may replace lost cells by differentiating
into functional neural tissue; modulate the immune system
to prevent further neurodegeneration and effect repair; or.
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system. With regard to the latter possibility, neurons of the
adult central nervous system require continued trophic
support from surrounding cells. For instance, oligodendro-
cytes and the myelin they produce support axons and
evidence from disease states suggests that loss of myelin
leads to progressive axonal degeneration (Griffiths et al.,
1998; Lappe-Siefke et al., 2003). If human MSCs are to be
used as therapeutic cell replacement therapies for neurolo-
gical disease, an understanding of their neurotrophic proper-
ties and mechanisms by which they may reduce neuronal
death is required.
Many intracellular signaling pathways have been impli-
cated in the process of neuronal cell death, and precise
mechanisms may vary dependent on specificity of the
environmental insult. For instance, toxic metabolites may
induce cell death by activating different intracellular
cascades to those induced by trophic factor withdrawal
(Cao et al., 2004). The death of neurons induced by trophic
factor withdrawal is an important process during develop-
ment of the central nervous system, in which competition for
neurotrophic factors shapes the integration of individual
components (Raff et al., 1994). The mechanisms by which
neurotrophic factors attenuate neuronal death have also
attracted much attention (Goldberg and Barres, 2000).
Neurotrophic factors may inhibit death-inducing pathways
and also activate a variety of cell survival pathways: several
are now well defined and a major role for the PI3kinase/Akt
pathway has emerged (Kaplan and Miller, 2000). This path-
way may be activated by a variety of trophic factors,
including brain-derived neurotrophic factor (BDNF) in vitro
(Zheng and Quirion, 2004).
In the current study we aimed to define mechanisms of
neuronal cell death under conditions of trophic deprivation
and exposure to nitric oxide, and to determine the influence
of factors released by human bonemarrow-derived mesench-Figure 1 (A) MSC-conditioned medium increases survival of
neurons exposed to trophic deprivation: Effect of chemically
defined medium with no serum (MIN), MSC-conditioned medium
(CM), MSC-conditioned medium plus LY290042 (10 μM; CM/LY),
and MSC-conditioned medium plus PD98059 (30 μM; CM/PD) on
live β-tubulin-positive cells per field. Controls were cultured in
2% B27 throughout and values expressed as a percentage of this
control. Neurons were cultured for 5 DIV and exposed to test
conditions for 3 DIV (n=5; ⁎⁎ Pb0.01). (B) MSC-conditioned
medium increases survival of neurons exposed to nitric oxide:
Effect of chemically defined medium with no serum (MIN),
DETANONOate (0.2 mM; NO), DETANONOate plus MSC-condi-
tioned medium (NO/CM), DETANONOate plus MSC-conditioned
medium plus LY290042 (10 μM; NO/CM/LY), and DETANONOate
plus MSC-conditioned medium plus PD98059 (30 μM; NO/CM/PD)
on live β-tubulin-positive cells per field. Controls were cultured
in 2% B27 throughout and values are expressed as a percentage
of this control. Neurons were cultured for 5 DIV and exposed to
test conditions for 3 DIV (n=4; ⁎⁎ Pb0.01). (C) Immunographs
showing the effect of DETANONOate (NO) and DETANONOate plus
MSC-conditioned medium (NO/CM) on neuronal survival (β-
tubulin staining; green) in cultures (5 DIV) exposed to test
conditions for 1 DIV. Nuclei stained with Hoechst (blue). Scale
bar: 20 μm.ymal stem cells on neuronal death and the intracellular
pathways activated by these stressors.
Results
MSC-conditioned medium attenuates trophic factor
withdrawal-induced neuronal death and nitric oxide
(NO)-mediated neuronal death
Cortical neurons (1.4×103 cells/mm2) were maintained in
B27-supplemented Dulbecco's modified Eagles medium
(DMEM) for 5 days in vitro (DIV) before exposure to DMEM
supplemented with chemically defined medium with no
serum (MIN). B27-supplemented DMEM is rich in trophic
support factors, whereas chemically defined medium with no
serum represents culture medium lacking in trophic support
Figure 2 (A) MSC-conditionedmedium activates Akt in neurons
exposed to trophic deprivation: Akt phosphorylation in neurons
(cultured for 5 DIV) exposed to chemically defined medium
with no serum (MIN), MSC-conditioned medium (CM), or MSC-
conditioned medium plus LY290042 (10 μM; CM/LY) for 1 h. Upper
panel shows phospho-Akt immunoblot and lower panel total Akt of
identical amounts of protein lysate. Representative blot of 3
independent experiments. (B) MSC-conditioned medium acti-
vates Akt in neurons exposed to DETANONOate: Akt phosphoryla-
tion in neurons (cultured for 5 DIV) exposed to 2% B27 (B27),
chemically defined medium with no serum (MIN), DETANONOate
(0.2 mM; NO), DETANONOate plus MSC-conditioned medium
(NO/CM), or DETANONOate plus MSC-conditioned medium plus
LY290042 (10 μM; NO/CM/LY) for 1 h. Upper panel shows phospho-
Akt immunoblot and lower panel total Akt of identical amounts of
protein lysate. Representative blot of 3 independent experi-
ments. (C) MSC-conditioned medium reduces p38 activation in
neurons exposed to DETANONOate: p38 phosphorylation in
neurons (cultured for 5 DIV) and exposed to 2% B27 (B27),
chemically defined medium with no serum (MIN), DETANONOate
(0.1 mM; NO), or DETANONOate plus MSC-conditioned medium
(NO/CM) for 6 h. Upper panel shows phospho-p38 immunoblot and
lower panel shows total p38 of identical amounts of protein
lysate. Representative blot of 3 independent experiments.
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for β-tubulin and the nuclear marker bisbenzamide, and
neuronal survival was determined. Neurons exposed to
chemically defined medium with no serum showed decreased
survival compared to control (Fig. 1A). Neurons exposed to
mesenchymal stem cell-conditioned medium showed
increased survival compared to those exposed to chemically
defined medium with no serum medium.
Cortical neurons (1.4×103 cells/mm2) were also exposed
to the nitric oxide donor DETANONOate (after 5 DIV
maintained in B27-supplemented DMEM). After a further 1
DIV of DETATNONOate exposure, cultures were fixed and
stained for β-tubulin and the nuclear marker bisbenzamide,
and neuronal survival was determined. Neurons exposed to
the DETANONOate showed decreased survival compared to
control, a process which was attenuated by MSC-conditioned
medium (Figs. 1B and 1C).
MSC-conditioned medium promotes neuronal
survival via PI3kinase/Akt-dependent pathways
In order to investigate intracellular mechanisms underlying
these phenomena we investigated signaling changes occur-
ring during trophic factor withdrawal and DETANONOate
exposure. Neurons were cultured as above for 5 DIV before
exposure to DMEM supplemented with 2% B27, DMEM
supplemented with chemically defined medium with no
serum, or chemically defined medium with no serum
containing DETANONOate. After 1 or 6 h of exposure, cells
were washed and lysed and immunoblotting for cell signal
intermediates was performed.
We determined the influence of MSC-conditioned medium
on signaling changes occurring during trophic factor with-
drawal or NO exposure. Exposure of neurons to MSC-
conditioned medium increased activation of Akt compared
to those exposed to chemically defined medium with no
serum medium alone (Fig. 2A). Akt activation was also seen
in neurons exposed to MSC-conditioned medium in the
presence of DETANONOate, compared to neurons exposed
to DETANONOate alone (Fig. 2B). Furthermore, addition of
the PI3kinase/Akt inhibitor LY290042 (10 μM) inhibited MSC-
conditioned medium-induced survival of cortical neurons
exposed to trophic factor withdrawal or NO exposure (Figs.
1A and 1B). The MAPkinase/Erk inhibitor PD98059 (30 μM) did
not inhibit the survival effect of MSC-conditioned medium
(Figs. 1A and 1B). Furthermore exposure of neurons to
chemically defined medium with no serum alone did not lead
to activation of p38 MAPkinase pathways, which occurred on
exposure to DETANONOate (Fig. 2C). MSC-conditioned
medium attenuated DETANONOate-induced p38 activation
within cortical neurons (Fig. 2C).
MSCs secrete BDNF
Given previous reports suggesting that MSCs secrete brain-
derived neurotrophic factor, we next sought to determine
whether BDNF is important in mediating, at least part, the
MSC effects on neuronal survival (Arnhold et al., 2006). BDNF
ELISA demonstrated significant amounts of BDNF secreted
from MSCs. Chemically defined medium with no serum
conditioned by MSCs (5×105 cells conditioned 1 ml ofmedium for 24 h) contained 190.5 pg/ml (+/– 12.56 SEM;
n=6; Fig. 3A) of BDNF. In order to demonstrate the functional
significance of BDNF within MSC-conditioned medium func-
tional BDNF blocking antibodies were used. Addition of
neutralising antibodies to BDNF (5 μg/ml; added with
medium conditioned by MSCs for either 1 DIV for NO-exposed
neurons or 3 DIV for trophically deprived neurons) signifi-
cantly reduced MSC-conditioned medium-induced attenua-
tion of neuronal death on trophic withdrawal and NO
exposure (Figs. 3B and 3C). Control nonselective mouse IgG
was also added to medium conditioned by MSCs, with no
effect on cell survival (data not shown).
We next determined whether recombinant BDNF
improved neuronal survival under conditions of trophic
factor withdrawal. Cortical neurons (1.4×103 cells/mm2)
were maintained in B27-supplemented DMEM for 5 DIV before
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medium with no serum or chemically defined medium with
no serum containing recombinant BDNF. After a further 3 DIV,
cultures were fixed and neuronal survival was determined.
Neurons exposed to the BDNF (both 10 and 100 ng/ml)
showed increased survival compared to those cultured in
chemically defined medium with no serum alone (Figs. 4A
and 4B). Addition of the PI3kinase/Akt inhibitor, LY290042,
significantly reduced the survival effect of BDNF. Further-
more exposure of cortical neurons to BDNF induced highlevels of phosphorylated-Akt compared to neurons exposed
to chemically defined medium with no serum alone (Fig. 4C).
Discussion
In this report we have shown that human bone marrow-
derived mesenchymal stem cells secrete factors which
protect rodent neurons from trophic deprivation and nitric
oxide-induced death. We have demonstrated that medium
conditioned by human MSCs influences intracellular signaling
within neurons. We have also shown that human MSCs secrete
brain-derived neurotrophic factor which acts as a neuropro-
tective agent via the PI3kinase/Akt pathway.
The prospect of stem cell therapies for neurodegenera-
tive disorders has created much interest (Rosser et al.,
2007). Specifically, human MSC transplantation has been
shown to improve the outcome in a variety of animal models
of neurological disease including stroke and spinal cord
injury (Zhang et al., 2004; Himes et al., 2006; Zhang et al.,
2006). In experimental autoimmune encephalomyelitis
(EAE), there is evidence that MSCs may improve clinical
outcome via immunomodulation, reduction in central ner-
vous system inflammation, and neuroprotection (Zappia et
al., 2005; Kassis et al., 2008). Inflammatory disorders, such
as EAE, are associated with elevated levels of nitric oxide
within the central nervous system, combined with reductions
in trophic support from surrounding glia (Kanwar et al.,
2004). The current study provides a potential mechanism by
which MSCs may protect neurons from NO-mediated damage
or trophic deprivation and may be important in determining
potential therapeutic targets for central nervous system
inflammatory disorders, such as multiple sclerosis.
Although the precise mechanisms by which MSCs act has
not been fully elucidated, it has been postulated that theyFigure 3 (A) Human MSCs produce BDNF: Production of BDNF
(pg/cell) by different MSC populations (derived from different
patients; MSC1–6). Chemically defined medium with no serum
(MIN), rat cortical neurons (6 DIV; Neuron), and rat cortical
neurons exposed to DETANONOate for 24 h (6 DIV; NeuronNO) are
used as controls. (B) Neutralising antibodies to BDNF attenuate
MSC-conditioned medium survival effects under conditions of
trophic deprivation: Effect of chemically defined medium with
no serum (MIN), MSC-conditioned medium (CM), and MSC-
conditioned medium plus anti-BDNF neutralising antibodies
(5 μg/ml CM/aBDNF) on live β-tubulin-positive cells per field.
Controls were cultured in 2% B27 throughout and values
expressed as a percentage of this control. Neurons were cultured
for 5 DIV and exposed to test conditions for 3 DIV (n=4;
⁎ Pb0.05). (C) Neutralising antibodies to BDNF attenuate MSC-
conditioned medium survival effects under conditions of
DETANONOate exposure: Effect of chemically defined medium
with no serum (MIN), DETANONOate (0.2 mM; NO), DETANONO-
ate plus MSC-conditioned medium (NO/CM), and DETANONOate
plus MSC-conditioned medium plus anti-BDNF neutralising
antibodies (5 μg/ml NO/CM/aBDNF) on live β-tubulin-positive
cells per field. Controls were cultured in 2% B27 throughout and
values expressed as a percentage of this control. Neurons were
cultured for 5 DIV and exposed to test condition for 3 DIV (n=3;
⁎ Pb0.05).
Figure 4 (A) Immunographs showing the effect of trophic
deprivation (MIN) and BDNF (10 ng/ml; BDNF) on neuronal
survival (β-tubulin staining; green) in cultures (5 DIV) exposed to
test conditions for 3 DIV. Nuclei stained with Hoechst (blue).
Scale bar: 40 μm. (B) BDNF increases neuronal survival: Effect of
chemically defined medium with no serum (MIN), BDNF 10 ng/ml
(BDNF10), BDNF 100 ng/ml (BDNF100), or BDNF 10 ng/ml plus
LY290042 (10 μM; B10/LY) on live β-tubulin-positive cells per
field. Controls were cultured in 2% B27 throughout and values
are expressed as a percentage of this control. Neurons were
cultured for 5 DIV and exposed to test conditions for 3 DIV (n=4;
⁎⁎ Pb0.01). (C) BDNF phosphorylates Akt: Akt phosphorylation in
neurons (cultured for 5 DIV) and exposed to 2% B27 (B27),
chemically defined medium with no serum (MIN), BDNF 10 ng/ml
(B10), BDNF 100 ng/ml (B100), or BDNF 10 ng/ml plus LY290042
(10 μM; B10LY) for 1 h. Upper panel shows phospho-Akt
immunoblot. Lower panel shows total-Akt immunoblot of same
membrane. Representative blot of 3 independent experiments.
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replacement of lost cells by differentiation into functional
neural tissue; modulation of the immune system to prevent
further neurodegeneration, cell fusion, or provision of
trophic support for the diseased nervous system. Previous
reports have demonstrated that bone marrow-derived stem
cells are able to eloborate various potentially neuroprotec-
tive growth factors in vitro including BDNF (Arnhold et al.,
2006; Neuhuber et al., 2005; Hokari et al., 2008). Human
MSCs have also been shown to release other neurotrophic
factors, such as nerve growth factor (NGF), neurotrophin-3
(NT-3), glial cell line-derived neurotrophic factor (GDNF),
fibroblast growth factor-2, and insulin-like growth factor
type 1 (Pisati et al., 2007; Boucherie et al., 2008; Crisostomoet al., 2008). There is also evidence that MSCs may alter
neurotrophic factor expression dependent on the environ-
ment in which they exist (Boucherie et al., 2008; Crisostomo
et al., 2008). Understanding the mechanisms and factors
involved in MSC-derived neuroprotection is an important
prerequisite to the design of future cell-based therapies for
neurodegenerative diseases.
Intracellular signaling underlying processes of neuronal
cell death is complex, but evidence points to a critical role
for both MAPkinase signaling pathways and PI3kinase/Akt
signaling (Vaillant et al., 1999). Members of MAPkinase
pathways are known to be activated by a variety of signals in
neurons and specifically p38 has been implicated in neuronal
cell death pathways (Harper and LoGrosso, 2001). Several
reports have shown p38 MAPkinase activation during NO
mediated neuronal death and trophic factors have been
shown to inhibit p38 signaling and promote survival in this
context (Lin et al., 2001; Ishikawa et al., 2003; Wilkins and
Compston, 2005).
The PI3kinase/Akt pathway is a critical cellular survival
pathway (Kaplan and Miller, 2000). Akt pathways are
particularly important in mediating neuronal survival, for
instance, in determining the response of sympathetic
neurons to depolarization and NGF exposure (Vaillant et
al., 1999; Crowder and Freeman, 1998). These reports again
highlight the convergence of antiapoptotic processes on Akt,
since both exposure to potassium chloride, leading to
depolarization of the cell, and NGF treatment of cells lead
to Akt phosphorylation and a reduction in apoptosis. The
PI3kinase/Akt pathway has also been implicated in the
survival of other neuronal types, such as sensory neurons,
cerebellar granule cells, and retinal ganglion cells (Klesse
and Parada, 1998; Diem et al., 2001; Encinas et al., 2001).
Many neurotrophic factors have been identified which
activate several intracellular pathways in vitro and the
requirement for combinations of factors is apparent for CNS
neurons, with the precise nature of such signals being
dependent on type, region, and age of neurons. BDNF is a
member of the neurotrophin family of growth factors that is
widely expressed in the adult and developing nervous
system. In vitro, BDNF has been shown to increase survival
of many neurons, including hippocampal and retinal ganglion
cells (Lindholm et al., 1996; Meyer-Franke et al., 1995).
BDNF activates a number of signaling pathways in neurons,
but PI3kinase/Akt pathways appear crucial in its survival-
promoting effects (Yamada et al., 2001).
We have demonstrated that human MSCs are strongly
neuroprotective in vitro and analysed some of the intracel-
lular signaling mechanism underlying these effects. Under-
standing the mechanisms by which human MSCs provide
protection for neurons is an important step in designing
rational therapies for neurodegenerative diseases.Materials and methods
Neuronal cell culture
Neuronal cultures were prepared from cortices of E16 rat
embryos as previously described (Wilkins et al., 2001).
Following enzymatic dissociation, cells were plated onto
poly-L-lysine coated 13-mm coverslips and cultured in
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ham, UK) supplemented with 2% B27 (Gibco, UK). After 6
DIV,N95% of cells were positive for the neuronal marker
β-tubulin. At this point, cultures were exposed to experi-
mental conditions. Chemically defined medium with no
serum consisted of DMEM supplemented with insulin-free
Sato (containing bovine serum albumin (100 μg/ml), trans-
ferrin (100 μg/ml), progesterone (0.06 μg/ml), putrescine
(16 μg/ml), selenite (0.04 μg/ml), thyroxine (0.04 μg/ml),
triiodothryonine (0.04 μg/ml)).
A stock solution (50 mM in 10 mM NaOH) of (Z)-1-[2-(2-
aminoethyl)-N-(2-ammonioethyl)amino]daizen-1-ium-1,2-
diolate] (DETANONOate; Alexis Biochemicals, Nottingham,
UK)was prepared immediately before use. In order to confirm
nitric oxide generation in cultures, a modified Greiss reaction
(Sigma, UK) was performed on culture supernatants after 24 h
of DETANONOate exposure. Recombinant BDNF was obtained
from Sigma. The pathway inhibitor PD98059 and neutralising
antibodies to BDNFwere obtained fromCalbiochem (USA) and
LY290042 from Sigma.
MSC culture
Bone marrow samples were obtained by orthopedic surgeons
at the Avon Orthopaedic Centre, Bristol, UK, with informed
written consent and hospital ethics committee approval.
Bone marrow was taken at the time of total hip replacement
surgery from the femoral shaft and placed into a sterile 50-
ml tubes containing 1000 IU heparin. Femoral shaft bone
marrow donors were healthy apart from osteoarthritis (those
with history of malignancy, immune disorders, or rheumatoid
arthritis were excluded), and were not receiving drugs
known to be associated with myelosuppression or bone-
marrow failure.
Femoral shaft marrow samples were broken up with a
scalpel and washed with DMEM until remaining material
(bone) looked white at the bottom of the 50-ml tube. All
washings were pipetted into a new 50-ml tube and kept for
centrifugation. The suspension was centrifuged and resus-
pended in DMEM and overlaid onto an equal volume of
Lymphoprep (Axis-Shield, Dundee, UK; density 1.077+/–
0.001 g/ml) and centrifuged at 600 g for 35 min at room
temperature to separate the mononuclear cells (MNC) from
neutrophils and red cells. The MNC layer was harvested and
washed twice in DMEM.
Isolated MNCs were centrifuged and resuspended in MSC
medium (consisting of DMEM with 10% FCS selected for the
growth of MSC (StemCell Technologies, London, UK), and 1%
penicillin and streptomycin (Sigma-Aldrich). Vented flasks
(25 cm2) containing 10 ml of MSC medium were seeded with
1×107 cells for primary culture. Flasks were incubated at
37 °C in a humidified atmosphere containing 5% CO2 and fed
every week with MSC medium by half medium exchange to
remove nonadherent hematopoietic cells until the adherent
fibroblast-like MSCs reached approximately 70% confluence.
On reaching confluence the adherent cells were resus-
pended using 0.25% trypsin (Sigma-Aldrich) and reseeded at
2.25×105 cells per (75 cm2) flask into first passage. Cultures
were then incubated, fed every week with MSC medium by
half medium exchange, and again trypsinized, a cell count
was taken and cells were reseeded at 2.25×105 cells per flask
(75 cm2).To ensure that a homogenous population of MSC had been
cultured immunophenotyping of surface markers was carried
out using flow cytometry according to previous reports
(Pittenger et al., 1999). Cells were examined at third
passage using APC-conjugated anti-CD105, APC-Cy7-conju-
gated anti-CD45 (eBioscience), PE– conjugated anti-CD166,
FITC-conjugated anti-CD90 (BD Biosciences), and with PE-
Cy7-conjugated anti-CD44 (Serotec). Mesenchymal stem
cells were induced into adipogenic, osteoblastic, and
chondrogenic differentiation by culturing MSC, at third
passage, in NH Adipodiff medium, NH Osteodiff medium,
and NH Chondrodiff medium (Miltenyi Biotec), respectively,
according to the manufacturers instructions. Adipogenic,
osteogenic, and chondrogenic differentiations were char-
acterized using immunofluorescent detection by indirect
labeling using a anti-lipoprotein lipase (Abcam), anti-alka-
line phosphatase (Abcam), and anti-human aggrecan (4F4)
(Santa Cruz Biotechnology), respectively (Gordon et al.,
2008; Gordon et al., 2008).
Preparation of mesenchymal stem cell-conditioned
medium
Confluent mesenchymal stem cell cultures, at third passage,
were washed in DMEM and cultured for 24 h in chemically
defined medium with no serum (described above). Media
were then removed and stored at-20 ˚C prior to use in
culture experiments.
Assays for cell survival and cell morphology
Evaluation of neuronal cell survival and morphology within
cultures was carried out by immunocytochemistical analysis
using antibodies against β-tubulin III (Sigma; 1:400). Cells
were stained after fixation with 4% paraformaldehyde and
treatment of cultures with 100% methanol at –20 °C for
10 min. Secondary antibodies coupled to FITC fluorochromes
were used to visualise primary antibody staining. Hoechst
33258 (bisbenzamide 1:5000) was used (10 min at room
temperature) for nuclear identification and morphological
assessment of cell survival. Nuclear morphology was assessed
for each cell analysed to determine whether it was alive or
undergoing apoptotic cell death. Neuronal survival was
assessed using counts of live β-tubulin-positive stained
cells, taking 5 random fields per culture and at least 3
cultures per experiment. In all cases, control cultures grown
throughout the experimental period in DMEM/2% B27 were
also analysed and values for experimental conditions divided
by this value, in order to standardize results between
experiments.
Immunoblotting for cell signaling proteins
Neurons were cultured at high density (2×106 per 6-well
plate) before exposure to test conditions. After set time
points, cells were lysed and stored in loading buffer,
consisting of 150 mM Tris-HCl, 8 M urea, 2.5% w/v SDS,
20% v/v glycerol, 10% v/v 2-mercaptoethanol, 3% w/v DTT,
0.1% bromophenol blue, pH 6.8, and stored at –20 °C until
use. Continuous gradient SDS-polyacrylamide gels (5–20%)
were used and equal quantities of cell lysates (protein
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Cheshire, UK)) run on each lane. After transfer to
nitrocellulose membrane (Hybond C-super, Amersham, UK)
and blocking in 4% w/v powdered milk, membranes were
incubated overnight in primary antibody at 4 °C (in TBS/5%
BSA). Antibodies used were phospho-p38 (Thr180/Tyr182),
total p38 antibody, phospo-Akt (ser473), and total Akt (all
1:1000, Cell Signal Technology, USA). Immunoreactivity was
visualized by secondary anti-rabbit HRP-conjugated anti-
bodies (1:2000; Dako) and enhanced chemiluminescence
(Renaissance ECL reagent, NEN Life Science Products,
Boston, MA).
BDNF ELISA
Mesenchymal stem cell-conditioned media (100 μl), derived
from MSCs (5×105 cells conditioned in 1 ml of chemically
defined medium with no serum for 24 h) at varying passages,
were analyzed by ELISA using the RayBio Human BDNF ELISA
kit (Raybiotech Inc., USA) according to the manufacturer's
instructions. All samples were analyzed in triplicate.
Statistical analysis
Statistical analysis on data expressed as a percentage of
control was performed on arcsine transformed values.
Counting data were analysed using nonparametric tests
(Kruskal-Wallis with post hoc Dunn's testing between groups).
Other data were analysed using one-way ANOVA with post
hoc testing for comparison of multiple sets (Neumann-Keuls).
Values are expressed as the mean+/– standard error of the
mean from at least 3 independent experiments, unless
otherwise stated.
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